Sean O’Sullivan, the lead investor of SOSV, will be doing a fireside chat on “Innovation at Scale”. With $300 million assets under management, SOSV backs more than 150 startups annually through its accelerators, including IndieBio and RebelBio. Come find out how SOSV became the most active investor in the life sciences and hear from the man himself on what the future holds and what he’s excited about investing in next.
Lora Kolodny covers startups and venture capital for CNBC.com in San Francisco. Previously she was an editor at TechCrunch and covered the venture capital beat with Dow Jones VentureWire and the Wall Street Journal in San Francisco. Lora began her business and tech reporting career as a staff reporter for Inc. magazine during the dotcom bust. She wrote a blog for the New York Times called “The Prize,” covering the winners, losers, innovation and deal-making around business and tech competitions. She is a graduate of Williams College. Reach her on Twitter @lorakolodny.